Which MS medication has been linked to macular edema?

• A. Chloroquine
• B. Glitazones
• C. Fingolimod (Gilenya)
• D. Retrovir

Answer: (C)

Fingolimod can cause macular edema, so this medication requires attention for retinal changes when treating someone with multiple sclerosis. The drug is an S1P receptor modulator that prevents lymphocytes from exiting lymph nodes, but that same signaling pathway operates in the retina to regulate vascular permeability. When Fingolimod disrupts this permeability control, fluid can accumulate in the macula, leading to cystoid macular edema.

Clinically, you’d want a baseline eye examination with optical coherence tomography before starting the drug and then follow-up imaging a few months after initiation—typically around three to four months—to catch any developing edema early. If macular edema develops, the usual management is to coordinate with the prescribing physician to discontinue Fingolimod, after which the edema often improves over time.

Other medications in the list have different ocular risk profiles. For example, chloroquine or hydroxychloroquine can cause a retinal toxicity over time (bull’s-eye maculopathy) rather than a drug-induced macular edema, and the others are not as closely linked to this specific retinal complication.